WAT

Waters Corporation
$376.43
-0.70 (-0.19%)
Mkt Cap 24.54B
Volume 375,497
52W Range 275.05-414.15
Sector Healthcare
Beta 1.20
EPS (TTM) 7.88
P/E Ratio 47.77
Revenue (TTM) 3.77B
Rev Growth (5Y) +6.0%
EPS Growth (5Y) +5.2%
AlphaVal · Fair Value
What we estimate one share is worth
$240.86
Overvalued strong signal
56.3% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Stable Earnings Power
70.3 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 3.17B 2.96B 2.96B 2.97B 2.79B 2.37B 2.41B 2.42B 2.31B 2.17B 2.04B 1.99B
Net Income 642.63M 637.83M 642.23M 707.75M 692.84M 521.57M 592.20M 593.79M 20.31M 521.50M 469.05M 431.62M
EPS 10.80 10.75 10.87 11.80 11.25 8.40 8.76 7.71 0.25 6.46 5.70 5.12
Free Cash Flow 539.81M 619.64M 442.18M 428.20M 579.01M 618.12M 479.26M 476.88M 607.17M 534.11M 457.28M 405.40M
FCF / Share 9.07 10.44 7.48 7.14 9.40 9.95 7.09 6.19 7.61 6.61 5.55 4.81
Operating CF 652.55M 762.12M 602.81M 611.66M 747.27M 790.51M 643.09M 604.45M 697.64M 629.08M 560.29M 511.65M
Total Assets 5.08B 4.55B 4.63B 3.28B 3.09B 2.84B 2.56B 3.73B 5.34B 4.66B 4.26B 3.88B
Total Debt 1.49B 1.70B 2.44B 1.66B 1.60B 1.45B 1.78B 1.15B 2.00B 1.83B 1.67B 1.46B
Cash & Equiv 587.83M 324.42M 395.08M 480.53M 501.23M 436.69M 335.71M 796.28M 642.32M 505.63M 487.67M 422.18M
Book Value 2.56B 1.83B 1.15B 504.49M 367.55M 232.14M (216.28M) 1.57B 2.23B 2.30B 2.06B 1.89B
Return on Equity 0.25 0.35 0.56 1.40 1.89 2.25 N/A 0.38 0.01 0.23 0.23 0.23
WAT News
Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call
Jul 02, 2026 02:00 AM · prnewswire.com
IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
Jun 24, 2026 04:00 AM · businesswire.com
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis
Jun 09, 2026 04:00 AM · prnewswire.com
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
Jun 08, 2026 04:00 AM · prnewswire.com
Why Is Waters (WAT) Up 8.7% Since Last Earnings Report?
Jun 04, 2026 08:35 AM · zacks.com
Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Jun 03, 2026 12:02 PM · seekingalpha.com
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
Jun 03, 2026 04:00 AM · prnewswire.com
Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research
Jun 01, 2026 04:00 AM · prnewswire.com
Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics
Jun 01, 2026 04:00 AM · prnewswire.com
Carnival: Calm Waters Despite Fuel Price Headwinds
May 30, 2026 09:46 PM · seekingalpha.com